PRME vs SANA: stock comparison and AI forecast
Prime Medicine, Inc. (PRME) and Sana Biotechnology, Inc. (SANA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
PRME Prime Medicine, Inc.
- Price
- $4.45 +42.9% · 6M
- Market Cap
- $807M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SANA Sana Biotechnology, Inc.
- Price
- $2.34 -33.1% · 6M
- Market Cap
- $700M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- PRME is 1.2 times larger than SANA by market capitalization ($807M against $700M).
- Over the last six months PRME returned +42.9% and SANA -33.1%.
- PRME carries 5.26 times debt per unit of equity, against 1.09 times for SANA.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | PRME | SANA |
|---|---|---|
| Market Cap | $807M | $700M |
| P/B Ratio | 20.27x | 3.88x |
| EPS | $-1.18 | $-0.73 |
| Book Value/Share | $0.22 | $0.60 |
| FCF/Share | $-0.86 | $-0.48 |
Profitability & Margins
| Metric | PRME | SANA |
|---|---|---|
| ROE | -472.0% | -82.8% |
| ROA | -75.5% | -39.7% |
| ROIC | -90.4% | -52.0% |
| Operating Margin | -4893.4% | – |
| Net Margin | -4678.6% | – |
| EBT Margin | -4893.4% | – |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | PRME | SANA |
|---|---|---|
| Current Ratio | 3.05x | 1.77x |
| D/E Ratio | 5.26x | 1.09x |
| Financial Leverage | 6.26x | 2.09x |
| Working Capital | $65M | $57M |
Cash Flow
| Metric | PRME | SANA |
|---|---|---|
| Operating Cash Flow | -$156M | -$142M |
| Free Cash Flow | -$157M | -$145M |
| Capital Spending | -$800K | -$4M |
Income Statement
| Metric | PRME | SANA |
|---|---|---|
| Operating Income | -$197M | -$157M |
| Net Income | -$188M | -$149M |
| R&D Expense | $146M | $128M |
Dividend & Shareholder Information
| Metric | PRME | SANA |
|---|---|---|
| Shares Outstanding | 181M | 299M |
PRME vs SANA: stock comparison and AI forecast
Which is bigger, PRME or SANA?
PRME is 1.2 times larger than SANA by market capitalization ($807M against $700M).
Which stock performed better over the last six months, PRME or SANA?
Over the last six months PRME returned +42.9% and SANA -33.1%.
Which one does Intratio's AI model rank higher, PRME or SANA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.